Does extragonadal presentation impart a worse prognosis to abdominal germ-cell tumours?
- 31 May 1992
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (4-5) , 825-828
- https://doi.org/10.1016/0959-8049(92)90123-j
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Germ cell tumour chemotherapyBritish Journal of Cancer, 1989
- Intensive induction chemotherapy for poor risk non-seminomatous germ cell tumoursEuropean Journal of Cancer and Clinical Oncology, 1989
- Bone disease in testicular and extragonadal germ cell tumoursBritish Journal of Cancer, 1988
- CARCINOMA-IN-SITU TESTIS IN PATIENTS WITH ASSUMED EXTRAGONADAL GERM-CELL TUMOURSThe Lancet, 1987
- Primary or Secondary Extragonadal Germ Cell Tumors?Journal of Urology, 1986
- Chemotherapy of extragonadal germ cell tumors.Journal of Clinical Oncology, 1985
- Occult Germ‐cell Testicular TumoursBritish Journal of Urology, 1983
- The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP)British Journal of Cancer, 1983
- Advanced Extragonadal Germ-Cell TumorsAnnals of Internal Medicine, 1982
- Vinblastine (VLB), bleomycin (BLEO), cis-diamminedichloroplatinum (DDP) in disseminated extragonadal germ cell tumors. A southwest oncology group studyCancer, 1980